The investment profit rate of the biotechnology industry is as high as 17.6%, twice that of the information industry. In the past ten years, the output value of the global biotechnology industry has increased at a rate of five times every three years. After a long period of development, 7a6431333361303036 of China's biochemical industry has a certain foundation. Especially after the reform and opening up, the development of biochemical industry has entered a new stage.

Compared with traditional chemical industry, the development of biochemical industry has obvious advantages. The state attaches great importance to the development of biochemical industry, especially in biochemical technology. China's "863" and "973" plans include biotechnology in key funding areas. The pace of chemical industrialization is accelerating, and the development of the biochemical industry is good; Xiang Jun analyzes that 20% -30% of chemical processes in the chemical industry will be replaced by biotechnology processes in the future, and the biotechnology industry will become one of the leading industries in the 21st century , Biochemical industry will become an important chemical industry in the 21st century. It is believed that due to the wide range of biochemicals and many industries involved, there are many companies engaged in biochemicals. Although the industry competition is becoming increasingly fierce, biochemicals have decreased significantly, but they are related to life sciences (mainly referring to pharmaceuticals and agricultural biochemistry Technology) Compared with the situation where the princes split up, the biochemical industry is still in full bloom, with hundreds of schools contending. There are large world companies engaged in life sciences such as Novartis and Jellicon, as well as large fine chemical companies such as DSM and Novo Nordisk, and of course there are small companies such as Altus that have expertise in a certain area. Moreover, as the world's major companies are shifting their attention to the life sciences, the flourishing situation of the biochemical industry will not change significantly in a long time.

Global biochemical annual sales are around US $ 40 billion, and the annual growth rate is about 8% -10%. From the perspective of product structure, the production scale of the biochemical field is extremely wide. The annual market demand is only kilograms of interferon, erythropoietin and other expensive products, and the annual demand for antibiotics, enzymes, food and feed additives exceeds 10,000 tons. , Daily-use and agricultural biochemical products and other low-priced products are almost equally divided. Specifically, the market share of high-priced products is 50% -60%, and the market share of low-priced products is 40% -50%. Moreover, according to the development trend of biochemical industry and people's emphasis on medicine and health, the development rate of high-priced products is higher than that of low-priced products.

Biochemical industry involves a wide range, many biochemical companies have their own expertise, and cooperation between them for commercial interests is also very active. In addition, with the addition of manufacturers engaged in traditional industries, due to technical and production reasons, they also cooperate frequently with companies engaged in the development and production of biochemicals. All of this makes the cooperation in the biochemical industry more and more extensive.